Buffalo’s First Biomedical Career Fair is focused on biomedical and life science careers within the region and beyond!
Sarah Beachy, PhD - Senior Program Officer and Director of the Roundtable on Genomics and Precision Health and the Forum on Regenerative Medicine
The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions related to science, technology, and medicine. If you are looking to learn more about translating your scientific skillsets into a path that may lead to a career in policy, please stop by to talk with Sarah.
Alan Belicha, PhD, Director, Business Development and Industry Engagement at Business & Entrepreneur Partnerships, University at Buffalo.
Prior to his transition into business development, Alan obtained a Ph.D. in molecular tumor immunology at Roswell Park Comprehensive Cancer Center and completed a postdoctoral fellowship at the Icahn School of Medicine at Mount Sinai in New York City.
During his time in NYC, Alan worked at Grey Healthcare Group, a healthcare marketing firm, at Ascent Biomedical Ventures, an early-stage venture fund, and as an independent strategy consultant eventually joining the Business Development team at Mount Sinai Innovation Partners (MSIP). At MSIP he was responsible for evaluating early stage life science technologies, developing a commercial strategy and ultimately partnering those assets with biotech and pharma companies ultimately contributing to the licensing of ~$850M of preclinical stage assets.
In addition to his current role at the State University of New York at Buffalo, Alan is the founder and CEO of MitoPath, a biotech company developing a gene-therapy for an extremely rare genetic disease called Mitochondrial NeuroGastroIntestinal Encephalomyopathy (MNGIE).
Grant Carr, PhD - Senior Director, Discovery Biology and Site Head AMRI Buffalo
AMRI is a leading contract research and manufacturing organization serving the pharmaceutical industry. Founded in 1991 as the World’s first contract medicinal chemistry provider, AMRI has remained a leading provider of drug discovery and development expertise and services to the biopharmaceutical industry. AMRI offers a broad portfolio of individual drug discovery services based on our biology, medicinal chemistry, in vitro ADMET and bioanalytical expertise, and has provided a comprehensive, integrated drug discovery solution to academics, virtual biotechs, biotechs and large Pharma since 2002. AMRI’s experience and expertise in drug discovery has translated into a high program success rate for the drug discovery industry. From 175 discovery programs, AMRI has generated 75 pre-clinical and clinical candidates, 166 issued patents and dozens of additional filings. For 33 recent oncology programs, AMRI has generated 15 pre-clinical and clinical candidates, to date and is one of only three integrated discovery centers for the National Cancer Institute’s NExT chemical biology consortium (the NCI NExT CBC). For scientists seeking an opportunity to enter the drug discovery and development field AMRI can be an exceptional choice.
Shawn Egan, PhD Citibank Equity Research is a role that requires an individual to have/develop both a strong scientific and financial skillset. Responsibilities include assessing the value of biotech stocks and communicating this to investors. This is typically accomplished by assessing the likelihood that companies' drugs in development will be successful in clinical trials and then forecasting the addressable market and drug penetration for each respective disease. Shawn received his PhD in Immunology from Roswell Park Comprehensive Cancer Center / University at Buffalo in 2015 and has served in an equity research position since 2016.
Colin Oliver, PhD MBA - Director Medical Consulting, Syneos Health
Colin completed his PhD at Roswell Park and his MBA in Buffalo. Colin has been a Medical Science Liaison for Onyx Pharmaceuticals. He later was the US Medical Affairs Lead at Prothenex prior to his current role in Consulting at Syneos Health.
ZeptoMetrix is a fully-integrated life sciences company that participates in the field of infectious disease diagnostics by providing products and services used from basic research through commercial clinical testing applications. Our laboratories require scientists skilled in microbiology, bacteriology, virology, immunology, and molecular biology techniques. As a $25M company with over 100 employees [~65 in Buffalo] experiencing healthy annual growth, we expect to continue expanding our workforce into the foreseeable future. Current and future positions at the company include a range of entry- to mid-level scientist positions, along with Quality Assurance/Regulatory Affairs [medical devices], Product and Project Management, Materials/Logistics, and other infrastructural roles needed to support our rapid growth.
Shawn Smith has been the President & CEO of ZeptoMetrix since December 2017. Shawn is a graduate from UB [Biochemical Pharmacology, 1987] and has spent most of his career involved with cell culture-based bioprocessing, including 18 years at GIBCO/Invitrogen/Life Technologies (now Thermo) in a variety of roles ranging from R&D to Operations to Commercial business management. He left WNY for several years to follow career opportunities in Southern California and then the Greater Boston area prior to returning ‘home’ to lead ZeptoMetrix.
Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Matthew Smonskey completed his doctorate through the Roswell Park Cancer Pathology and Prevention program in 2014. He also performed his post-doctoral work in the Roswell Park Department of Pharmacology and Therapeutics in 2015. Matthew has been working at Thermo Fisher Scientific for four years and is currently a manager in Bioproduction R&D located in Grand Island, NY.
Tactiva Therapeutics Inc. is a pre-clinical stage, start-up biotech company at Buffalo, NY. The company is based on the innovative TCR-T cell therapy technology from Roswell Park Comprehensive Cancer Center that aim to harness the power of both immune cell therapy and hematopoietic stem cell biology to fight deadly human diseases like solid tumor. We are looking for a scientist(s) with a strong background in the area of immunology, HSC biology, or gene therapy. Experiences with primary human cell (immune cells and/or HSC cell) culture, engineering, investigation, and manipulation are preferred. As the research leader at Tactiva Therapeutics, I have worked in the cell therapy area for more than 5 years on one approved T cell therapy product as well as several early cell therapy assets. I look forward to working with the research team closely to bring the revolutionary TCR-T therapy to those patients in need in the near future.
Jennifer L Blickwedehl, PhD - Professor of Biology Trocaire College is a private, career-oriented College that provides the necessary skills, industry knowledge and hands-on experience for employment in healthcare, hospitality, business and technology. Responsibilities of a full-time faculty member include; carrying a full-time course load, developing educational pedagogy, pursuing academic research, advising students and serving in the greater higher education landscape of Western New York. Jennifer received her PhD in Immunology from Roswell Park Comprehensive Cancer Center / University at Buffalo in 2007 and has been a full-time biology faculty member since 2010.
Daniel Dulgerian, Director of Marketing & Technology - Empire Genomics
Anna-Barbara Hachmann received her Ph.D. in Microbiology at Cornell University in 2010. She worked on the Human Microbiome Project as a post-doctoral fellow at Harvard Medical School and the Antimicrobial Discovery Center at Northeastern University and as a Scientist at BioHelix. In 2013 she joined Thermo Fisher Scientific as a Senior Scientist in R&D where she develops cell culture media for vaccine and bioproduction applications.
Heidi Iuvino, BSc MBA, (Account Manager) worked in Cancer Genetics at Roswell Park and then decided to pursue a career in Sales. She has held positions as Regional Manager, National Sales Director and Account Manager, while working at Fermentas, Thermo, Immco, Agilent and now New England Biolabs (NEB)
Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs is now a recognized world leader in the discovery and production of enzymes for molecular biology. New England Biolabs’ laboratories more closely resemble those of a research institute than a biotech company, and with good reason; the over 100 scientists at NEB are engaged in research in areas that include enzyme analysis and engineering, epigenetics, RNA biology and parasitology. As a result, NEB scientists have published over 1100 papers to date. In an effort to foster science education, NEB scientists also supervise post-doctoral associates, student interns and Ph.D. students engaged in research projects. With this dual focus on both basic and applied research, NEB’s culture is collaborative and academic. We have relationships with a number of outside laboratories and host weekly seminars that bring together leading researchers with our community to facilitate the exchange of ideas.
New England Biolabs has had the honor of being lauded with the “2009 Recycling Business Award” and the “2010 Best Places to Work” award by "The Scientist" magazine.
Roswell Park Student Retreat & Buffalo Biomedical Career Fair Tentative Schedule
|10:15 - 10:25 a.m.||Abigail Cornwall|
|10:25 - 10:35 a.m.||Sanam Dharma|
|10:35 - 10:45||Q & A|
|10:45 - 10:55 a.m.||Kah Teong Soh|
|10:55 - 11:05 a.m.||Q&A|
|11:05 - 11:15||Tim Stachowski|
|11:15 - 11:25||Sasheen Hamilton|
|11:25 - 11:35||Q&A|
|11:35 - 11:45||Brendan Zangari|
|11:45 - 11:55||Aaron Holling|
|11:55 - 12:05 p.m.||Q&A|
|12:05 - 12:15||Jeffrey Martin|
|12:15 - 12:25||Ashley Mussell|
|12:30 - 1:30||Lunch and Set up for Buffalo Biomedical Career Fair|
|BUFFALO BIOMEDICAL CAREER FAIR|
|1:30 - 1:40||Murray Cutler, PhD (Athenex)|
|1:45 - 1:55||Shawn Smith (Zeptometrix)|
|2:00 - 2:10||Sarah Beachy, PhD (National Academy of Sciences)|
|2:15 - 2:25||Shawn Egan, PhD (Citi Bank)|
|2:30 - 2:40||Alan Belicha, PhD (U at Buffalo, Research & Economic Development)|
|2:40 - 3:40||Networking and Employer Tabling|
|3:40 -3:50||Grant Carr, PhD (AMRI Global)|
|3:55 - 4:05||Matthew Smonskey, PhD (ThermoFisher)|
|4:10 - 4:20||Xiaohua Wang (Tactiva)|
|4:25 - 4:35||Colin Oliver, PhD MBA (Syneos Health)|
|4:40 - 5:00||Q & A Panel|
|5:00 - 6:00||Mixer - Wyndham Garden Hotel Buffalo Downtown|
Frequently Asked Questions:
Q: Who can attend?
A: PhD and MS Students within their final year. Postdoctoral fellows, scientists and any research staff.
Q: Where can I park for the fair?
A: The career fair is located in the Zebro Conference Room near the corner of Ellicott and Virginia Streets in Buffalo, NY. Pay per hour parking is available along Virginia and Ellicott Streets. A public parking lot is also located on Ellicott Street just before crossing Virginia. For NFTA metro users, exit at Allen St and walk on Carlton Street (away from Main St). Make a right on Ellicott and left on Virginia. For NFTA users, park and ride service is available from University Station (3435 Main Street Buffalo, NY 14214) and LaSalle Station (3030 Main Street, Buffalo, NY 14214).